NIH-funded research Sbir 2 grant

Developing advanced MRI technology to identify early signs of Alzheimer's disease

Official title: ADVANCED COMPREHENSIVE MAGNETIC RESONANCE SOLUTION FOR THE NONINVASIVE CHARACTERIZATION OF HIGH RESOLUTION METABOLIC BIOMARKERS OF RISK IN PATIENTS WITH ALZHEIMER'S DISEASE AND DEMENTIA

Funded at Advanced Imaging Research, INC. · NIH-11130773 · Data updated 2026-11-12

This study is testing a new technology that improves brain scans to help find early signs of Alzheimer's disease, so patients can get diagnosed sooner and manage their condition better.

More s Disease research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionAdvanced Imaging Research, INC.
NIH-funded
Lab location1 site (Cleveland, United States)
Project startSeptember 20, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$1,275,000
NIH project number4R44AG085817-02
Project IDNIH-11130773 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for Alzheimer's disease, including those with a family history or early cognitive symptoms.

Less likely to help

Patients with advanced Alzheimer's disease or those who do not exhibit any risk factors for the disease may not benefit from this research.

What this research studies

This research focuses on creating a cutting-edge hardware-software system called ADRD360 that enhances magnetic resonance imaging (MRI) and spectroscopy (MRS) to detect metabolic biomarkers associated with Alzheimer's disease and related dementias. By improving the resolution of brain imaging, the project aims to identify early indicators of Alzheimer's risk, which could lead to timely interventions. The approach involves optimizing radio-frequency coils and imaging techniques to achieve unprecedented clarity in brain scans. Patients may benefit from earlier diagnosis and better management of their condition through this innovative technology.

Why it matters

Potential benefit: If successful, this research could enable earlier detection of Alzheimer's disease, allowing for timely treatment and improved patient outcomes.

How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for early detection of Alzheimer's, suggesting that this approach could build on existing knowledge.

Where this research is happening

  • Advanced Imaging Research, INC.
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Srinivasan, Ravi — Advanced Imaging Research, INC.
  • Study coordinator: Srinivasan, Ravi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.